CEO Connect

CEO Blog

My First 100 Days:  It’s hard to believe that my first 100 days with Rx-360 is in the books.  My biggest daily reflection is how honored I am to be representing a great and dedicated Membership.  Its evident that each and every person involved with Rx-360, whether an employee or member understands the cause, and why our great organization exists.

As I embark on my second 100 days, my primary thought as of late is “what are we rallying around”?  Ten years ago it was the Heparin Scare, are we still rallying around that, and championing it from a historical perspective, through our continued work in supply chain security?   What is the new initiative?  Is it interaction internationally (China and India)?  Is it helping membership chart through the waters of blockchain technologies?   As both members and non-members, I am sure there is a massive real time library of ideas just waiting to be put into action.  This is what excites me about Rx-360…we can facilitate and drive your ideas!  I encourage everyone, take the time, reach out to me directly, lets discuss what’s on the horizon.  Let’s align on how we can collaborate to make our organizations, products, and supply chain secure.  It’s all about the safety of the patient.

I also want to send out a thank you to the members of the Data Integrity Working Group who diligently collaborated and completed the recently released GMP Audit Manual: Data Governance and Data Integrity.   Special thanks to all the authors:

  • Elayne Kimmett , Biogen
  • Neelima Raval, Daiichi Sankyo
  • Cathlin Shapiro, Bristol Myers Squibb
  • Jim Henderson, Eli Lilly
  • Jayne Nicholas, Bristol Myers Squibb
  • Lucien Sergile, Eli Lilly
  • Dan Ewald, Boehringer Ingelheim
  • Norma Amilpa, Eli Lilly
  • Gayle Heffernan, Daiichi Sankyo
  • Jennifer Baughman, MilliporeSigma
  • Darlene Looney, Johnson & Johnson
  • Dale Herbranson, West Pharma
  • Barb Unger, Unger Consulting
  • Ben Mills, BSI